Lung Cancer Clinical Trial

Implementation of a System-level Tobacco Treatment Intervention

Summary

The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.

View Full Description

Full Description

In particular the study aims to see if participants are asked about their smoking status and what services are offered if someone indicates being a former or current smoker. Findings from this study will help improve a standard of care at this clinic and allow us to understand what type of tobacco treatment services are preferred by patients.

Adaption of CEASE will entail exit interviews with patients and individual interviews with clinical staff to identify and address facilitators and barriers to the implementation process.
Effectiveness of CEASE will be measured through questionnaires & biochemical verification of smoking status using a pre-test/post-test study design before (usual care)and after implementation (CEASE)

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age ≥ 18
Have an actual or potential diagnosis of thoracic malignancy
Able to read and write in English.
Current or recent former smoker (defined as having smoked within past 6 months)
Must have an active telephone number.

Exclusion Criteria:

Former smoker greater than 6 months.

Have any of the below conditions needing immediate medical intervention

Hypercalcemia causing lethargy and confusion,
Acute respiratory distress
Dehydration
Hypotension

Study is for people with:

Lung Cancer

Estimated Enrollment:

263

Study ID:

NCT02816697

Recruitment Status:

Active, not recruiting

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Brigham and Women's Hospital
Boston Massachusetts, 02115, United States
Dana Farber Cancer Institute
Boston Massachusetts, 02115, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

263

Study ID:

NCT02816697

Recruitment Status:

Active, not recruiting

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider